The DOI matches its OpenAlex record; 61 of the 61 references it cites were found in a registry or an index.
C-reactive protein: a critical update
Open accessAbstract
In the mid 1990s, immunoassays for C-reactive protein (CRP), with greater sensitivity than those previously in routine use, revealed that increased CRP values, even within the range previously considered normal, strongly predict future coronary events. These findings triggered widespread interest, especially, remarkably, in the US, where the clinical use of CRP measurement had been largely ignored for about 30 years. CRP production is part of the nonspecific acute-phase response to most forms of inflammation, infection, and tissue damage and was therefore considered not to provide clinically useful information. Indeed, CRP values can never be diagnostic on their own and can only be interpreted at the bedside, in full knowledge of all other clinical and pathological results. However, they can then contribute powerfully to management, just as universal recording of the patient’s temperature, an equally nonspecific parameter, is of great clinical utility. The present torrent of studies of CRP in cardiovascular disease and associated conditions is facilitated by the ready commercial availability of automated CRP assays and of CRP itself as a research reagent. However, unlike the earlier rejection in the US of CRP as an empirical test because of its perceived lack of specificity, the current enthusiasm over CRP in cardiovascular disease is widely characterized by failure to recognize appropriately the nonspecific nature of the acute-phase response, and by lack of critical biological judgment. Quality control of the source, purity, and structural and functional integrity of the CRP, and the relevance of experimental design before ascribing pathophysiological functions, are also often ignored. This article provides information about CRP as a protein and an acute-phase reactant, and a knowledge-based framework for interpretation and analysis of clinical observations of CRP in relation to cardiovascular and other diseases. We also review the properties of CRP, its possible role in pathogenesis of disease, and our own observations that identify it as a possible therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
Self-citationDanesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
Self-citationThompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S. D., Gallimore, J. R., & Group, M. B. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,500
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,478
Pepys, M. B., & Baltz, M. L. (1983) · Advances in Immunology · doi:10.1016/s0065-2776(08)60379-x · Cited by 1,272
Self-citationRelation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
for the MRFIT Research Group, Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,097
Zwaka, T. P., Hombach, V., & Torzewski, J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1194 · Cited by 845
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
Cermak, J., Key, N., Bach, R., Balla, J., Jacob, H., & Vercellotti, G. (1993) · Blood · doi:10.1182/blood.v82.2.513.513 · Cited by 839
The physiological structure of human C-reactive protein and its complex with phosphocholine
Thompson, D., Pepys, M. B., & Wood, S. P. (1999) · Structure · doi:10.1016/s0969-2126(99)80023-9 · Cited by 818
Self-citationRidker, P. M., Rifai, N., & Clearfield, M. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00460-3 · Cited by 760
Freeman, D. J., Norrie, J., Caslake, M. J., Gaw, A., Ford, I., Lowe, G. D. O., O’Reilly, D. S. J., Packard, C. J., Sattar, N., & for the West of Scotland Coronary Prevention Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1596 · Cited by 728
Gershov, D., Kim, S., Brot, N., & Elkon, K. B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1353 · Cited by 695
Fröhlich, M., Imhof, A., Berg, G., Hutchinson, W. L., Pepys, M. B., Boeing, H., Muche, R., Brenner, H., & Koenig, W. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1835 · Cited by 688
Self-citationCushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660
Body mass index, diabetes, and C-reactive protein among U.S. adults.
Ford, E. S. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1971 · Cited by 644
Vigushin, D. M., Pepys, M. B., & Hawkins, P. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116336 · Cited by 636
Self-citationElevation of C-reactive protein in “active” coronary artery disease
Berk, B. C., Weintraub, W. S., & Alexander, R. W. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90079-g · Cited by 588
Does Exercise Reduce Inflammation? Physical Activity and C-Reactive Protein Among U.S. Adults
Ford, E. S. (2002) · Epidemiology · doi:10.1097/00001648-200209000-00012 · Cited by 575
Torzewski, J., Torzewski, M., Bowyer, D. E., Fröhlich, M., Koenig, W., Waltenberger, J., Fitzsimmons, C., & Hombach, V. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.9.1386 · Cited by 561
Effect of alcohol consumption on systemic markers of inflammation
Imhof, A., Froehlich, M., Brenner, H., Boeing, H., Pepys, M. B., & Koenig, W. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04170-2 · Cited by 559
Self-citationTargeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
Pepys, M. B., Herbert, J., Hutchinson, W. L., Tennent, G. A., Lachmann, H. J., Gallimore, J. R., Lovat, L. B., Bartfai, T., Alanine, A., Hertel, C., et al. (2002) · Nature · doi:10.1038/417254a · Cited by 540
Self-citationChang, M.-K., Binder, C. J., Torzewski, M., & Witztum, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192399699 · Cited by 521
Griselli, M., Herbert, J., Hutchinson, W. L., Taylor, K. M., Sohail, M., Krausz, T., & Pepys, M. B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1733 · Cited by 508
Self-citationSerum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
Bickerstaff, M. C. M., Botto, M., Hutchinson, W. L., Herbert, J., Tennent, G. A., Bybee, A., Mitchell, D. A., Cook, H. T., Butler, P. J. G., Walport, M. J., et al. (1999) · Nature Medicine · doi:10.1038/9544 · Cited by 489
Self-citationHormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein
Ridker, P. M., Hennekens, C. H., Rifai, N., Buring, J. E., & Manson, J. E. (1999) · Circulation · doi:10.1161/01.cir.100.7.713 · Cited by 443
Chambers, J. C., Eda, S., Bassett, P., Karim, Y., Thompson, S. G., Gallimore, J. R., Pepys, M. B., & Kooner, J. S. (2001) · Circulation · doi:10.1161/01.cir.104.2.145 · Cited by 438
Self-citationC-Reactive Protein Colocalizes With Complement in Human Hearts During Acute Myocardial Infarction
Lagrand, W. K., Niessen, H. W. M., Wolbink, G.-J., Jaspars, L. H., Visser, C. A., Verheugt, F. W. A., Meijer, C. J. L. M., & Hack, C. E. (1997) · Circulation · doi:10.1161/01.cir.95.1.97 · Cited by 388
Differentiation Between Obesity and Insulin Resistance in the Association With C-Reactive Protein
McLaughlin, T., Abbasi, F., Lamendola, C., Liang, L., Reaven, G., Schaaf, P., & Reaven, P. (2002) · Circulation · doi:10.1161/01.cir.0000041046.32962.86 · Cited by 373
Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction.
de Beer, F. C., Hind, C. R., Fox, K. M., Allan, R. M., Maseri, A., & Pepys, M. B. (1982) · Heart · doi:10.1136/hrt.47.3.239 · Cited by 358
Self-citationAnzai, T., Yoshikawa, T., Shiraki, H., Asakura, Y., Akaishi, M., Mitamura, H., & Ogawa, S. (1997) · Circulation · doi:10.1161/01.cir.96.3.778 · Cited by 335
Regulation of complement activation by C-reactive protein
Mold, C., Gewurz, H., & Du Clos, T. W. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00007-7 · Cited by 326
Bhakdi, S., Torzewski, M., Klouche, M., & Hemmes, M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2348 · Cited by 326
Solid phase radioimmunoassays for human C-reactive protein
Shine, B., de Beer, F. C., & Pepys, M. B. (1981) · Clinica Chimica Acta · doi:10.1016/0009-8981(81)90005-x · Cited by 319
Self-citationCOMPLEMENT ACTIVATION BY C‐REACTIVE PROTEIN COMPLEXES*
Volanakis, J. E. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22140.x · Cited by 278
Pietlla, K. O., Harmoinen, A. P., Jokiniitty, J., & Pasternack, A. I. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015068 · Cited by 263
Paris, J. A., & Hawkins, F. (1848) · BMJ · doi:10.1136/bmj.s1-12.23.638 · Cited by 262
Hutchinson, W. L., Koenig, W., Fröhlich, M., Sund, M., Lowe, G. D. O., & Pepys, M. B. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.7.934 · Cited by 250
Self-citationRisk factors for coronary heart disease and acute-phase proteins. A population-based study
Danesh, J. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1309 · Cited by 240
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers
Volanakis, J. E., & Wirtz, K. W. A. (1979) · Nature · doi:10.1038/281155a0 · Cited by 236
Coronary C-reactive protein distribution: its relation to development of atherosclerosis
Zhang, Y. X., Cliff, W. J., Schoefl, G. I., & Higgins, G. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00105-7 · Cited by 196
de Beer, F. C., Soutar, A. K., Baltz, M. L., Trayner, I. M., Feinstein, A., & Pepys, M. B. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.1.230 · Cited by 182
Self-citationPHYLOGENETIC ASPECTS OF C‐REACTIVE PROTEIN AND RELATED PROTEINS*
Baltz, M. L., De Beer, F. C., Feinstein, A., Munn, E. A., Milstein, C. P., Fletcher, T. C., March, J. F., Taylor, J., Bruton, C., Clamp, J. R., et al. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22125.x · Cited by 172
Self-citationPhosphorylcholine: friend or foe of the immune system?
Harnett, W., & Harnett, M. M. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01419-4 · Cited by 167
C-reactive protein: binding to lipids and lipoproteins.
Pepys, M. B., Rowe, I. F., & Baltz, M. L. (1985) · PubMed · Cited by 164
Self-citationSTUDIES OF ACUTE PHASE PROTEIN
Kushner, I., & Kaplan, M. H. (1961) · The Journal of Experimental Medicine · doi:10.1084/jem.114.6.961 · Cited by 163
Isolation and characterization of C-reactive protein and serum amyloid P component in the rat.
de Beer, F. C., Baltz, M. L., Munn, E. A., Feinstein, A., Taylor, J., Bruton, C. J., Clamp, J. R., & Pepys, M. B. (1982) · PubMed · Cited by 158
Self-citationSzalai, A. J., McCrory, M. A., Cooper, G. S., Wu, J., & Kimberly, R. P. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363820 · Cited by 145
C-reactive protein reacts with the U1 small nuclear ribonucleoprotein.
Clos, T. W. D. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2553 · Cited by 124
Kushner, I., Rakita, L., & Kaplan, M. H. (1963) · Journal of Clinical Investigation · doi:10.1172/jci104715 · Cited by 116
Comparative studies on the binding properties of human and rabbit C-reactive proteins.
Oliveira, E. B., Gotschlich, E. C., & Liu, T. Y. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.3.1396 · Cited by 98
C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction
Ueda, S., Ikeda, U., Yamamoto, K., Takahashi, M., Nishinaga, M., Nago, N., & Shimada, K. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90164-7 · Cited by 79
Human C-reactive protein does not bind to fcγRIIa on phagocyti cells
Saeland, E., van Royen‐Kerkhof, A., Hendriksen, K. A. W., Vilé-Weekhout, H., Rijkers, G. T., Sanders, E. A. M., & van de Winkel, J. G. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12418 · Cited by 45
Lack of specific receptors for C-reactive protein on white blood cells
Hundt, M., Zielinska‐Skowronek, M., & Schmidt, R. E. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200112)31:12<3475::aid-immu3475>3.0.co;2-1 · Cited by 43
Oral contraceptive use is associated with a systemic acute phase response
Fröhlich, M., Döring, A., Imhof, A., Hutchinson, W. L., Pepys, M. B., & Köenig, W. (1999) · Fibrinolysis and Proteolysis · doi:10.1054/fipr.1999.0037 · Cited by 30
Self-citation
Research works printed but not linked: 4
- de Beer, 1982, Immunology., 45, 55
- Pepys, 1985, Int. Rev. Exp. Pathol., 27, 83
- Tracy, 1996, Circulation., 93, 622
- Danesh, 1998, J. Am. Coll. Cardiol., 279, 1477
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Obesity and the Metabolic Syndrome in Children and Adolescents
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,459
Role of C-Reactive Protein at Sites of Inflammation and Infection
Sproston, N. R., & Ashworth, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00754 · Cited by 3,029
Metadata
- Authors
- Pepys, M. B., & Hirschfield, G. M.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-06-15
- Volume
- 111
- Issue
- 12
- Pages
- 1805-1812
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2024886564
- Cited by
- 3,503
- References
- 61
- FWCI
- 27.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.